HealthEquity, Inc. (HQY)

HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market....

HealthEquity (HQY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....

HQY stock gains post Q3 results as earnings and revenue top estimates, supported by rising HSAs and stronger margins....

HealthEquity, Inc. (HQY) Q3 2026 Earnings Call Transcript...

The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street es...

HealthEquity (HQY) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.9 per share. This compares to earnings of $0.78 per share a year ago....

Highlights of the third quarter include: Revenue increased 7% to $322.2 million. Net income per diluted share rose to $0.59 from $0.06 one year ago, and non-GAAP net income per diluted share increased...

HealthEquity, Inc. remains an asset-light growth opportunity, with a $120/share price target supported by strong Q2 FY26 results. HQY's recurring, asset-linked revenues, 70%+ gross margins, and expand...

Advantage Alpha Capital Partners LP reduced its stake in shares of HealthEquity, Inc. (NASDAQ: HQY) by 27.8% during the undefined quarter, according to its most recent 13F filing with the SEC. The ins...